Cormorant Asset Management, LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Cormorant Asset Management, LP

$1.3 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $8.72 Million - $15.3 Million	104,894 Added 131.12%	184,894 $26.9 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $8.81 Million - $11.4 Million	80,000 New	80,000 $9.49 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $13.2 Million - $21 Million	-200,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $14.4 Million - $20.6 Million	-225,000 Reduced 52.94%	200,000 $13.7 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $4.88 Million - $7.37 Million	-75,000 Reduced 15.0%	425,000 $36.4 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $5.9 Million - $7.8 Million	-100,000 Reduced 16.67%	500,000 $32.5 Million
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $7.99 Million - $20.5 Million	-275,551 Reduced 31.47%	600,000 $43.9 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $3.42 Million - $7.13 Million	-124,449 Reduced 12.44%	875,551 $29.8 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $11.5 Million - $16.2 Million	-281,400 Reduced 21.96%	1,000,000 $54.4 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $10 Million - $13.3 Million	-268,600 Reduced 17.33%	1,281,400 $53.5 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $17.9 Million - $30.2 Million	450,000 Added 40.91%	1,550,000 $67.9 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $15.5 Million - $24 Million	450,000 Added 69.23%	1,100,000 $56.6 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $11.6 Million - $16.7 Million	390,000 Added 150.0%	650,000 $24 Million
Q3 2018 Nov 14, 2018	SELL	$32.79 - $43.0 $811,060 - $1.06 Million	-24,735 Reduced 8.69%	260,000 $9.76 Million
Q1 2018 May 15, 2018	SELL	$22.49 - $34.56 $293,899 - $451,630	-13,068 Reduced 4.39%	284,735 $7.34 Million
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $6.09 Million - $10.6 Million	297,803	297,803 $8.04 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Account